RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Scientific Notation LOD The new serology test helps in detection of antibodies of the immunoglobulin class G (IgG) — a crucial component of an adaptive immune response — which typically reflects continued immunity. The assay utilizes multiplexing to simultaneously detect antibodies to three SARS-CoV-2 antigens and comprises multiple internal controls to offer a more extensive and reliable assessment of the immune response compared to other serology assays.
Luminex is expanding COVID-19 testing offerings into serology testing with this first multi-antigen IgG assay. This highlights the company’s focus in taking steps to support laboratories and research institutions that are committed toward meeting the continued high demand for a range of testing solutions.